** daily **
** weekly **
** daily - finviz **
** monthly - finviz **
Sunday, August 25, 2013
Amgen (AMGN) near $10.5B deal to buy Onyx (ONXX)
SAN FRANCISCO (MarketWatch) -- Amgen Inc. (AMGN) is reportedly near a deal to acquire Onyx Pharmaceuticals Inc. (ONXX) for $10.5 billion. The New York Times reported that sources close to the companies said the deal could be officially announced by Monday. By acquiring Onyx, Amgen would obtain the rights to Kyprolis, a drug used in treating multiple myeloma, as well as revenue from the liver and kidney cancer drug Nexavar. The deal would value Onyx at about $125 a share.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment